Amphotericin B Lipid Complex for the Treatment of Recurrent Blastomycosis of the Brain in a Patient Previously Treated With Itraconazole

South Med J. 2001;94(5) 

In This Article

Abstract and Introduction

This is the first reported case of cerebral blastomycosis successfully treated with amphotericin B lipid complex.

Itraconazole is the preferred therapy for blastomycosis not involving the central nervous system. The drug has an efficacy rate of approximately 90% in patients who complete 6 months of therapy.[1] Itraconazole and ketoconazole do not penetrate the central nervous system well, and there are reports of cerebral blastomycosis in patients treated with ketoconazole for pulmonary disease.[2,3] The following is a case of cerebral blastomycosis treated with amphotericin B lipid complex in a patient who had been treated with itraconazole for pulmonary blastomycosis 4 years earlier. This appears to be the first reported case of successful treatment of central nervous system blastomycosis with amphotericin B lipid complex.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: